About Us

For over 25 years our Cesa’s world-wide collaboration of Universities, Laboratories, independent doctors and researchers has successfully developed a wide range of Omni spectrum anti-microbials and anti-inflammatories.

Cesa’s success is largely due to a novel approach in drug development. Rather than looking for candidates using time consuming in-vitro test and mouse models, Cesa identifies the targets frequency and through complex algorithms determines a frequency that either over amplifies it, inverts it or disturbs it. With this blue print new molecules are not discovered but created and synthesized from scratch. The major advantage of specifically designed drugs over traditional discovered and adapted ones are the increased efficacy and minimal or no side effects.

At the same time Cesa relies heavily on the official protocols prescribed by FDA and EMA and collaborates closely with Universities and Institutions to confirm the safety and efficacy of our claims.

Since yearly globally tens of billion viral infections represent such a massive scale and responsibility, Cesa Alliance is now no more focused on its solutions as a business but a drive for human salvation. Therefor all patents and licenses are now part of the Ulloa Health Solutions Foundation, which closely collaborates with Government Programs and other Foundations.